Tag : CRON

Cannabis News Market Watch

Cronos Group Announces $100M Bought Deal

Editor
The Cronos Group (NASDAQ: CRON) (TSX-V: CRON) announced this morning that the company has entered into an agreement with  GMP Securities L.P. and BMO Capital Markets to sell 10,420,000 common shares, on a “bought deal” basis, at a price of $9.60 per common share, which will lead to a raise of $100.0 million. ...
Cannabis News Global Market Watch

MedMen Signs Joint Venture with Cronos Group to Enter Canadian Cannabis Market

Editor
Cronos Group Inc. (Nasdaq: CRON) (TSX-V: CRON), a licensed producer of cannabis in Canada, Germany, Isreal, and Australia, and MedMen, one of the leading cannabis companies in the United States, announced a cross border joint venture today that will allow MedMen to extend its retail chain and branded products to...